š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The purpose of this study was to assess the safety and intraocular pressure...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2011-02
Trial ID
NCT01336569
Treatments Being Tested
The purpose of this study is to demonstrate superior intraocular pressure (...
Status
Completed
Location
Multiple Locations
Start Date
2013-12
Trial ID
NCT02003391
The purpose of this study was to assess the efficacy and tolerability of ch...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT01327599
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of transitio...
Status
Completed
Location
Mainz
Start Date
2007-08
Trial ID
NCT00519753
Treatments Being Tested
This is a single-center, cross-over comparison parallel group randomized tr...
Status
Completed
Location
Ophthalmology Department, Hospital Kuala Lumpur
Start Date
2010-08
Trial ID
NCT01168414
The purpose of this study is evaluate adherence to DuoTravĀ® when reinforced...
Status
Completed
Location
France
Start Date
2008-05
Trial ID
NCT00676637
Treatments Being Tested
Glaucoma is one of the leading causes of blindness worldwide that is a chro...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT03966560
The purpose of the study is to compare adherence in patients on a fixed com...
Status
Completed
Location
Zaragoza
Start Date
2007-10
Trial ID
NCT00508469
The purpose of this study to assess the safety and efficacy of changing to ...
Status
Completed
Location
Multiple Locations
Start Date
2010-10
Trial ID
NCT01230736
Treatments Being Tested
Hypothesis: * H1: Efficacy of Duotrav will be superior to Xalacom at 24 ho...
Status
Completed
Location
Ophthalmic Consultant Centres
Start Date
2009-01
Trial ID
NCT00887029
Treatments Being Tested